ESR1 and breast carcinoma: Specific to breast cancer, the enrichment of the “breast cancer regulation by Stathmin1” (P = 10−3.92) pathway is interesting since the overexpression of Stathmin1 correlates with loss of the ER (Curmi et al., 2000) and with aggressive breast tumor phenotypes (Obayashi et al., 2017).